BioSpace News Archive

Company provides 2020 product revenue guidance range of $89 million to $93 million representing growth of approximately 20% to 25% over preliminary 2019 full year results

Editas Medicine, Inc., a leading genome editing company, and Sandhill Therapeutics, Inc., a cellular immuno-oncology company, announced a strategic research collaboration, license, and option agreement to combine their respective genome editing and cell therapy technologies to discover, develop, and manufacture allogeneic engineered natural killer cells and non-alpha beta T cell medicines for the treatment of cancer.

President and CEO Sanjeev Luther to discuss the status of clinical trials for lead compound CPI-613® (devimistat) and provide update on drug development pipeline

In a presentation to investors on Wednesday, January 15, 2020, at 10:30 a.m. PST at the 38th Annual J.P. Morgan Healthcare Conference, Editas Medicine, Inc. President and CEO Cynthia Collins will discuss the Company’s progress on developing in vivo and engineered cell medicines and building the leading genomic medicine company.

Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with Diabetes

Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M.1, on track for market leadership in 2020.

New clinical trial will assess first-of-its-kind MitraClip™ transcatheter mitral valve repair against current standard of care surgery in a new, expanded patient population

VolitionRx Limited provided an update on its Nu Q™ Clinical Assays which use a magnetic particle-based assay format.

The Muscular Dystrophy Association and AavantiBio, a biotechnology company developing a gene-targeting therapy for Friedreich’s ataxia, announced the award of MDA Venture Philanthropy funding totaling $1,076,232 to advance AavantiBio’s phase 2 clinical trial of a gene-replacement therapy for the disease.

New partnerships further Cigna’s strategy to connect customers to care everywhere and meet them where they are - at home, at work, on the go